| The GALAXY-1 Project | The GALAXY-1 Project: Galactose - the Ideal Carbohydrate Supplement for Exercise | NCT05986500 |
| Galactose Supplementation for the Treatment of MOGHE | Galactose Supplementation for the Treatment of Patients With Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE): a Pilot Trial | NCT04833322 |
| Galactose Mediated Glycogen Resynthesis | Galactose Mediated Glycogen Resynthesis and the Effects on Metabolism During Subsequent Exercise | NCT03903861 |
| Effect of Galactose Ingestion on Postprandial Lipemia | The Acute Effects of Galactose Ingestion on Oral Fat Tolerance | NCT03439878 |
| Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema | Diabetic Macular Oedema: Quantification of the Effect of Rising the Intracapillary Osmotic Pressure With Intravenous Galactose on the Retinal Thickness | NCT00427986 |
| Residual galactose oxidation capacity and galactosylation abnormalities as possible predictors for galactose tolerance and outcome in patients with galactose-1-phosphate uridyltransferase deficiency | Residual galactose oxidation capacity and galactosylation abnormalities as possible predictors for galactose tolerance and outcome in patients with galactose-1-phosphate uridyltransferase deficiency - Galactose oxidation and galactosylation in Classical Galactosemia | NL-OMON46279 |
| Using D-Galactose as a food supplement in Congenital Disorders of Glycosylation (CDG) | Using D-Galactose as a food supplement in Congenital Disorders of Glycosylation (CDG) - Using Galactose in CDG | NL-OMON44612 |
| Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome | Effect of Oral Galactose on the Level of Focal Sclerosis Permeability Factor and Proteinuria in Children With Steroid Resistant Nephrotic Syndrome: A Pilot Study | NCT01113385 |
| Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 | Effect of Galactose on Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS)and Chronic Kidney Disease Stage 5 | NCT00816504 |
| Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor | Effect of Galactose on Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS) | NCT00816478 |
| Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 | Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 | NCT03404856 |
| Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation | Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation | NCT02955264 |
| Efficacy of oral galactose in in Children with multi drug Resistant Nephrotic Syndrome | A 12-Week Placebo-Controlled Randomized Trial of Oral Galactose for Reduction of Proteinuria in Children with Multi-Drug Resistant Nephrotic Syndrome - GALANT | CTRI/2017/12/010830 |
